Company Filing History:
2 out of 810 
2 out of 121 
Years Active: 2022-2024
Title: Lilach Sheiner: Innovator in Protein Delivery Systems
Introduction
Lilach Sheiner is a prominent inventor based in Glasgow, GB. She has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for delivering proteins to the central nervous system (CNS). With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Lilach's latest patents focus on engineered parasites for delivering proteins to the CNS. The first patent provides nucleic acid constructs and pharmaceutical compositions that facilitate the delivery of a protein-of-interest to a tissue-of-interest, such as the CNS. This method aims to treat pathologies that can be addressed through the administration of therapeutic polypeptides. The second patent also centers on engineered Toxoplasma parasites, offering similar constructs and methods for effective protein delivery to the CNS.
Career Highlights
Throughout her career, Lilach has worked with notable institutions, including Ramot at Tel Aviv University Ltd. and the University of Glasgow. Her research has garnered attention for its potential to revolutionize treatment options for various neurological conditions.
Collaborations
Lilach has collaborated with esteemed colleagues, including Oded Rechavi and Shahar Bracha, contributing to a dynamic research environment that fosters innovation.
Conclusion
Lilach Sheiner's work in protein delivery systems exemplifies the intersection of biotechnology and therapeutic innovation. Her patents represent a significant advancement in the field, with the potential to improve treatment outcomes for patients with CNS-related pathologies.